Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009 May;127(2):97-100.
doi: 10.1590/s1516-31802009000200008.

Artificial oxygen carriers as a possible alternative to red cells in clinical practice

Fabiano Timbó Barbosa  1 , Mário Jorge Jucá, Aldemar Araujo Castro, José Lira Duarte, Luciano Timbó Barbosa
Affiliations
Review

Artificial oxygen carriers as a possible alternative to red cells in clinical practice

Fabiano Timbó Barbosa et al. Sao Paulo Med J. 2009 May.

Abstract
in English, Portuguese

Fluid resuscitation is intended to eliminate microcirculatory disorders and restore adequate tissue oxygenation. The safety limits for a restrictive transfusion policy are given by patients' individual tolerance of acute normovolemic anemia. Artificial oxygen carriers based on perfluorocarbon or hemoglobin are attractive alternatives to allogenic red blood cells. There are many risks involved in allogenic blood transfusions and they include transmission of infections, delayed postoperative wound healing, transfusion reactions, immunomodulation and cancer recurrence. Regardless of whether artificial oxygen carriers are available for routine clinical use, further studies are needed in order to show the safety and efficacy of these substances for clinical practice.

Os fluidos de ressuscitação são utilizados para abolir os distúrbios microcirculatórios e restaurar a adequada oxigenação tissular. Os limites de segurança na prática da transfusão restrita são dados pela tolerância individual do paciente na anemia normovolêmica aguda. Os transportadores artificiais de oxigênio baseados no perfluorocarbono e na hemoglobina são opções atrativas para a transfusão alogênica de células vermelhas. Os riscos da transfusão sanguínea alogênica são muitos e incluem a transmissão de infecções, retardo na cicatrização pós-operatória, reações transfusionais, imunomodulação e risco de recorrência do câncer. Independentemente de os carreadores artificiais de oxigênio estarem disponíveis para o uso clínico rotineiro, mais estudos são necessários para mostrar a segurança e a eficácia dessas substâncias na prática clínica.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: None

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Brunskill S, Prowse C, Garrioch M, et al. Blood substitutes for avoiding allogeneic blood transfusion. The Cochrane Library. http://mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD004894/fr... Accessed in 2009 (Feb 3)
    1. Henkel-Honke T, Oleck M. Artificial oxygen carriers: a current review. AANA J. 2007;75(3):205–211. - PubMed
    1. Amberson WR, Jennings JJ, Rhode CM. Clinical experience with hemoglobin-saline solutions. J Appl Physiol. 1949;1(7):469–489. - PubMed
    1. Nouwairi NS. The risks of blood transfusions and the shortage of supply leads to the quest for blood substitutes. AANA J. 2004;72(5):359–364. - PubMed
    1. Creteur J, Vincent JL. Hemoglobin solutions. Crit Care Med. 2003;31(12 Suppl):S698–S707. - PubMed